
Michael J. Hicks
Examiner (ID: 3788, Phone: (571)272-2670 , Office: P/2165 )
| Most Active Art Unit | 2165 |
| Art Unit(s) | 2165 |
| Total Applications | 451 |
| Issued Applications | 261 |
| Pending Applications | 26 |
| Abandoned Applications | 166 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18210459
[patent_doc_number] => 20230056721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/963607
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17963607
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/963607 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | Oct 10, 2022 | Abandoned |
Array
(
[id] => 18178018
[patent_doc_number] => 20230038747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => VOLATILE OILY COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/958876
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/958876 | VOLATILE OILY COMPOSITION | Oct 2, 2022 | Abandoned |
Array
(
[id] => 18278415
[patent_doc_number] => 20230093887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF POST-OPERATIVE COGNITIVE DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/935667
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935667
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/935667 | Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction | Sep 26, 2022 | Issued |
Array
(
[id] => 19059031
[patent_doc_number] => 11938226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Abiotic anti-VEGF nanoparticle
[patent_app_type] => utility
[patent_app_number] => 17/934727
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17941
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934727 | Abiotic anti-VEGF nanoparticle | Sep 22, 2022 | Issued |
Array
(
[id] => 19396174
[patent_doc_number] => 12070503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Transdermal carrier
[patent_app_type] => utility
[patent_app_number] => 17/934056
[patent_app_country] => US
[patent_app_date] => 2022-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 32
[patent_no_of_words] => 22928
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934056 | Transdermal carrier | Sep 20, 2022 | Issued |
Array
(
[id] => 18628123
[patent_doc_number] => 20230286952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => HERBICIDAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/945221
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17945221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/945221 | Herbicidal compounds | Sep 14, 2022 | Issued |
Array
(
[id] => 20005805
[patent_doc_number] => 20250144027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => METHOD FOR CARTILAGE REGENERATION AND REGROWTH FOLLOWING INJURY
[patent_app_type] => utility
[patent_app_number] => 18/691159
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2377
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18691159
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/691159 | METHOD FOR CARTILAGE REGENERATION AND REGROWTH FOLLOWING INJURY | Sep 12, 2022 | Pending |
Array
(
[id] => 18251715
[patent_doc_number] => 20230078754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => FORMULATIONS OF (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE
[patent_app_type] => utility
[patent_app_number] => 17/929396
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929396 | Formulations of (R)-2-amino-3-phenylpropyl carbamate | Sep 1, 2022 | Issued |
Array
(
[id] => 19656848
[patent_doc_number] => 20240423913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => TREATMENT USING THERMOSENSITIVE LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 18/294183
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294183
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/294183 | TREATMENT USING THERMOSENSITIVE LIPOSOMES | Aug 15, 2022 | Pending |
Array
(
[id] => 18270932
[patent_doc_number] => 20230092174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => ACTIVE AGENT-CONTAINING ARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/878947
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17878947
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/878947 | ACTIVE AGENT-CONTAINING ARTICLES | Aug 1, 2022 | Abandoned |
Array
(
[id] => 19431122
[patent_doc_number] => 20240299620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => BIOENERGETIC-ACTIVE MATERIAL AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/574727
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18574727
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/574727 | BIOENERGETIC-ACTIVE MATERIAL AND USE THEREOF | Jul 31, 2022 | Pending |
Array
(
[id] => 18938223
[patent_doc_number] => 20240033362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => LIPID COMPOSITION FOR THE DELIVERY OF THERAPEUTIC CARGOS
[patent_app_type] => utility
[patent_app_number] => 17/874818
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/874818 | LIPID COMPOSITION FOR THE DELIVERY OF THERAPEUTIC CARGOS | Jul 26, 2022 | Abandoned |
Array
(
[id] => 17958529
[patent_doc_number] => 20220339109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => DRUG DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/863884
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/863884 | Drug delivery system | Jul 12, 2022 | Issued |
Array
(
[id] => 17981118
[patent_doc_number] => 20220347154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => SLOW RELEASE CANNABINOIDS AND PRODUCTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/863428
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/863428 | Slow release cannabinoids and products thereof | Jul 12, 2022 | Issued |
Array
(
[id] => 17981174
[patent_doc_number] => 20220347210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and Use
[patent_app_type] => utility
[patent_app_number] => 17/861413
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861413 | Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and Use | Jul 10, 2022 | Abandoned |
Array
(
[id] => 18893777
[patent_doc_number] => 20240009262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => CLEANSING PAD AND COMPOSITION FOR REDUCING TOXINS
[patent_app_type] => utility
[patent_app_number] => 17/861210
[patent_app_country] => US
[patent_app_date] => 2022-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861210 | CLEANSING PAD AND COMPOSITION FOR REDUCING TOXINS | Jul 8, 2022 | Abandoned |
Array
(
[id] => 19722667
[patent_doc_number] => 20250025418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => HYALURONIC ACID-LIPID DERIVATIVE, LIPID NANOPARTICLE COMPRISING SAME, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/577456
[patent_app_country] => US
[patent_app_date] => 2022-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18577456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/577456 | HYALURONIC ACID-LIPID DERIVATIVE, LIPID NANOPARTICLE COMPRISING SAME, AND USE THEREOF | Jul 6, 2022 | Pending |
Array
(
[id] => 19417172
[patent_doc_number] => 20240293295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => AQUEOUS MICROCAPSULE DISPERSION
[patent_app_type] => utility
[patent_app_number] => 18/573452
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573452
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573452 | AQUEOUS MICROCAPSULE DISPERSION | Jun 28, 2022 | Pending |
Array
(
[id] => 18107940
[patent_doc_number] => 20230000820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => SOLID DOSAGE FORM OF N-1-PYRROLIDINE-N-5-(3-TRIFLUOROMETHOXY)PHENYL BIGUANIDE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/850018
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850018 | SOLID DOSAGE FORM OF N-1-PYRROLIDINE-N-5-(3-TRIFLUOROMETHOXY)PHENYL BIGUANIDE AND USES THEREOF | Jun 26, 2022 | Abandoned |
Array
(
[id] => 17928513
[patent_doc_number] => 20220323638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => METHOD FOR PREPARATION OF TISSUE ADHESIVE PATCHES
[patent_app_type] => utility
[patent_app_number] => 17/850565
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 244
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850565
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850565 | Method for preparation of tissue adhesive patches | Jun 26, 2022 | Issued |